EURneffy® approved as the first needle-free anaphylaxis treatment of adults and children in the UK | ALK Poland

EURneffy® approved as the first needle-free anaphylaxis treatment of adults and children in the UK

Link

https://www.globenewswire.com/news-release/2025/07/18/3117864/0/en/EURneffy-app…

Created date

Fri, 07/18/2025 - 12:00

Nasdaq ID

3117864

Last updated: 2025.07.18